Skip to content

Clinical trials

Metabolic Syndrome trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolic Syndrome Country / region: Germany Clear all

71 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20042
20053
20063
20076
20088
20095
20103
20111
20125
20134
20141
20151
20163
20176
20183
20192
20202
20212
20222
20232
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed48
Unknown status12
Recruiting5
Terminated4
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Erlangen-Nürnberg Medical School10
Charite University, Berlin, Germany9
German Institute of Human Nutrition6
Novartis4
Hannover Medical School3
University of Hohenheim3
Bristol-Myers Squibb2
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company2
GWT-TUD GmbH2
Ludwig-Maximilians - University of Munich2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolic Syndrome71
Obesity20
Hypertension12
Overweight11
Diabetes Mellitus, Type 210
Diabetes Mellitus7
Non-alcoholic Fatty Liver Disease5
Dyslipidemias4
Inflammation4
Insulin Resistance4

Trials

Showing 26 to 50 of 71. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.